Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|
126
Metagenomi Therapeutics
MGX
$32.1M
| – | – | – | – |
|
|
OBX
127
Obsidian Therapeutics
OBX
$754M
| – | – | – | – |
|
128
Prime Medicine
PRME
$635M
| – | – | – | – |
|
|
SCTX
129
Scribe Therapeutics Inc
SCTX
$388M
| – | – | – | – |
|
|
SLBT
130
SL Science Holding Ltd
SLBT
$976M
| – | – | – | – |
|
131
DELISTED
Turnstone Biologics
TSBX
| – | – | – | – |
|